The Genetics and Biology of PADMAL
At a Glance
PADMAL is a genetic brain small-vessel disease caused by a COL4A1 regulatory change that disables miR-29 control. Extra collagen thickens and narrows vessel walls, mainly reducing blood flow in the pons; one affected parent can pass the variant to half of their children.
While many genetic diseases are caused by a “broken” gene that stops working, PADMAL is unusual because it involves a genetic regulatory mechanism that works too hard. The biology of PADMAL centers on the COL4A1 gene, which provides the blueprint for a type of collagen that strengthens your blood vessels [1][2].
In PADMAL, the mutation does not change the collagen protein itself; instead, it breaks the “brake” that tells the body when it has made enough. This leads to a chain reaction that gradually changes the architecture of the small vessels in your brain [3][4].
The 3’-UTR and the Broken Brake
To understand PADMAL, it helps to look at the 3’-UTR (the 3’ untranslated region). Think of a gene like a recipe. The “coding region” is the list of ingredients, but the 3’-UTR is a set of instructions at the end that helps regulate how much is produced [2].
Within this region of the COL4A1 messenger RNA, there is a specific docking site for a tiny molecule called microRNA-29 (or miR-29). Normally, miR-29 acts like a brake: it binds to the messenger RNA and prevents the body from overproducing collagen [2][5].
- The Mutation: In patients with PADMAL, a single letter in that docking site is changed (most commonly the *c.32G>A or *c.32G>T variant) [1][5].
- The Result: Because the docking site is altered, the miR-29 “brake” can no longer latch onto the messenger RNA.
- Upregulation: Without the brake, COL4A1 expression is upregulated, meaning the body continuously pumps out extra COL4A1 protein [2][3].
What Happens Inside the Vessels?
This overproduction of collagen has a direct physical effect on the basement membrane—the thin, flexible layer of tissue that supports and surrounds every small blood vessel [3].
As extra collagen builds up, the basement membrane becomes significantly thickened and scarred, a process called hyalinization [4][3]. This thickening takes up space inside the vessel, causing the “tunnel” where blood flows (the lumen) to narrow or develop stenosis [4]. Eventually, the vessel becomes so narrow that blood can no longer reach the brain tissue, leading to the small strokes and “raisin bread” spots characteristic of PADMAL [6][4].
PADMAL vs. Other COL4A1 Disorders
It is important to distinguish PADMAL from other “COL4A1-related angiopathies,” though there is significant overlap.
- Many other mutations in this gene are missense mutations, where an ingredient in the recipe is swapped for a “wrong” one (often an amino acid called glycine). These structural mutations create weak collagen that often makes vessels prone to larger hemorrhages (bleeding) [7][8].
- The PADMAL Phenotype: Because PADMAL is primarily a problem of quantity (too much collagen) rather than quality (weak collagen), it most commonly causes a predominantly ischemic (lack of blood flow) pontine syndrome [7][9]. However, small microbleeds can still occur in PADMAL, and bleeding risk is not eliminated [3][6].
How PADMAL is Inherited
PADMAL is an autosomal dominant condition. This means you only need one mutated copy of the gene (from either parent) to develop the condition [3].
- 50% Chance: A person with a confirmed pathogenic PADMAL variant has a 50% chance of passing the variant to each of their children, regardless of sex [3][10]. However, inheriting the variant does not mean the child will have the exact same symptoms, age of onset, or severity as the parent.
- De Novo Mutations: You may be the first person in your family to have this condition due to a de novo mutation (a change that happened spontaneously) [2][5].
- Hidden Family History: A lack of known family history does not prove a mutation is de novo. It could be due to unrecognized strokes, mild symptoms (reduced penetrance), early deaths from other causes, or small families. Even if your parents test negative via a blood test, laboratory limits or parental mosaicism (where only some cells have the mutation) mean inheritance is still occasionally possible [5][11].
Because the genetics are complex, working with a genetic counselor is the best way to navigate testing for your family, especially ensuring they understand the difference between a “pathogenic variant” and a “variant of uncertain significance” before making predictive testing decisions [10].
Common questions in this guide
What genetic change causes PADMAL?
How does the COL4A1 change affect blood vessels in PADMAL?
What is the chance of passing PADMAL to a child?
Can PADMAL occur without a family history?
Does PADMAL cause brain bleeding?
How should relatives be tested for PADMAL?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Can you confirm if my specific mutation is the c.*32G>A or c.*32G>T variant in the 3'-UTR region, and is it classified as 'pathogenic'?
- 2.Since this is an 'upregulation' mutation rather than a structural one, how does that affect my personal risk for brain bleeds compared to other COL4A1 variants?
- 3.Are there specific labs or imaging you recommend for my eyes or kidneys to check for systemic COL4A1 involvement?
- 4.Given that this is autosomal dominant, what is the process for screening my siblings or adult children if they are interested?
- 5.If my parents' genetic tests are negative, does that fully confirm my case was a de novo (new) mutation?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (11)
- 1
Cervical Spinal Involvement in a Chinese Pedigree With Pontine Autosomal Dominant Microangiopathy and Leukoencephalopathy Caused by a 3' Untranslated Region Mutation of COL4A1 Gene.
Zhao YY, Duan RN, Ji L, et al.
Stroke 2019; (50(9)):2307-2313 doi:10.1161/STROKEAHA.119.024875.
PMID: 31366314 - 2
Disruption of a miR-29 binding site leading to COL4A1 upregulation causes pontine autosomal dominant microangiopathy with leukoencephalopathy.
Verdura E, Hervé D, Bergametti F, et al.
Annals of neurology 2016; (80(5)):741-753 doi:10.1002/ana.24782.
PMID: 27666438 - 3
A Novel Mutation in COL4A1 Gene in a Chinese Family with Pontine Autosomal Dominant Microangiopathy and Leukoencephalopathy.
Li Q, Wang C, Li W, et al.
Translational stroke research 2022; (13(2)):238-244 doi:10.1007/s12975-021-00926-0.
PMID: 34415564 - 4
'Raisin bread sign' feature of pontine autosomal dominant microangiopathy and leukoencephalopathy.
Kikumoto M, Kurashige T, Ohshita T, et al.
Brain communications 2023; (5(6)):fcad281 doi:10.1093/braincomms/fcad281.
PMID: 37953842 - 5
A patient with pontine autosomal dominant microangiopathy and leukoencephalopathy caused by a de novo 3' untranslated region mutation of COL4A1 gene: case report and literature review.
Xie F, Li S, Hu X, Li W
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2025; (46(6)):2833-2838 doi:10.1007/s10072-025-08025-w.
PMID: 39976879 - 6
Pontine autosomal dominant microangiopathy with leukoencephalopathy: Col4A1 gene variants in the original family and sporadic stroke.
Roos J, Müller S, Giese A, et al.
Journal of neurology 2023; (270(5)):2631-2639 doi:10.1007/s00415-023-11590-9.
PMID: 36786861 - 7
Monogenic causes of cerebral small vessel disease and stroke.
Guey S, Chabriat H
Handbook of clinical neurology 2024; (204()):273-287 doi:10.1016/B978-0-323-99209-1.00018-1.
PMID: 39322384 - 8
Main features of COL4A1-COL4A2 related cerebral microangiopathies.
Guey S, Hervé D
Cerebral circulation - cognition and behavior 2022; (3()):100140 doi:10.1016/j.cccb.2022.100140.
PMID: 36324412 - 9
Monogenic cerebral small-vessel diseases: diagnosis and therapy. Consensus recommendations of the European Academy of Neurology.
Mancuso M, Arnold M, Bersano A, et al.
European journal of neurology 2020; (27(6)):909-927 doi:10.1111/ene.14183.
PMID: 32196841 - 10
Hereditary Cerebral Small Vessel Diseases and Stroke: A Guide for Diagnosis and Management.
Guey S, Lesnik Oberstein SAJ, Tournier-Lasserve E, Chabriat H
Stroke 2021; (52(9)):3025-3032 doi:10.1161/STROKEAHA.121.032620.
PMID: 34399586 - 11
Hereditary cerebral small vessel disease and stroke.
Søndergaard CB, Nielsen JE, Hansen CK, Christensen H
Clinical neurology and neurosurgery 2017; (155()):45-57 doi:10.1016/j.clineuro.2017.02.015.
PMID: 28254515
This page explains PADMAL genetics and COL4A1 biology for educational purposes and does not replace medical advice. A neurologist or genetic counselor can interpret your variant and family testing options.
Get notified when new evidence is published on Pontine autosomal dominant microangiopathy with leukoencephalopathy.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.